『Effective and powerful blood pressure lowering agent
‘Irbetan Series’ released』
KyungDong Pharm Co., Ltd. announced on June 21, 2011 that it is an ARB blood pressure lowering agent. ‘Irbetan Series’is released. The Irbetan series is a product whose main ingredient is Irbesartan, an ARB-type blood pressure lowering agent, and a total of four items, including single drugs and combination drugs, are scheduled to be released.
KyungDong Pharm Co., Ltd. has grown around its antihypertensive portfolio, establishing a strong market position with medicines including calcium channel blockers (CCBs), ACE inhibitors and beta-blockers. Following the launch of the losartan-based Rosata series in 2008 and the candesartan-based Cansata series in April 2011, the new Irbetan series is the company’s third angiotensin II receptor blocker (ARB) series, developed to strengthen its position in the hypertension treatment market.
The Irbetan series is a drug that has a better blood pressure lowering effect compared to existing drugs and also has the effect of suppressing the occurrence of renal failure in patients with type 2 diabetes. Therefore, it is easy to control various complications and accompanying diseases caused by high blood pressure, and the combination drug containing the diuretic hydrochlorothiazide quickly and powerfully controls blood pressure in patients who have failed to control blood pressure with monotherapy. It is a drug with excellent tolerability and safety, so the patient's compliance with the medication is very good. In the future, KyungDong Pharm Co., Ltd. plans to solidify its image as a company specializing in high blood pressure treatment by continuously producing and releasing blood pressure lowering drugs that show strong and excellent blood pressure control properties.
♠ Product Information ♠
|
Category |
Irbetan tablet 150mg |
Irbetan tablet 300mg |
Irbetan Plus Tablets |
Irbetan Plus F Tablet |
|
Ingredient content |
Irbesartan 150mg |
Irbesartan 300mg |
Irbesartan 150mg Hydrochlorothiazide 12.5mg |
Irbesartan 300mg Hydrochlorothiazide 12.5mg |
|
Appearance |
A white or almost white, biconvex, oval, film-coated tablet. |
White and oval Film coated tablets |
pink oval Film coated tablets |
pink oval Film coated tablets |
|
Indications |
As a treatment therapy for essential hypertension and high blood pressure, renal disease in type 2 diabetic patients with high blood pressure |
Treatment of essential hypertension | ||
|
Packaging unit |
30 tablets |
30 tablets, 100 tablets |
30 tablets, 100 tablets |
30 tablets, 100 tablets |
|
Reimbursement Code |
648103010 |
648102930 |
648102960 |
648102950 |
※ Please refer to the product manual for other details such as dosage, precautions for use, etc.